Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Prot# AVF2562s: Phase II Trial of Bevacizumab in Combination with FOLFIRI Chemotherapy as First-Line Therapy of Colorectal Cancer: The BAFIL (Bevacizumab and 5-FU, Irinotecan, Leucovorin) Trial (NU Prot# NU V04I8)
Mulcahy, Mary Frances
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
9/23/05
→
9/30/09
Funding
Genentech, Inc.
(AVF2562s)
View all
View less